Kratom Side Effects
Kratom should be discontinued due to serious adverse effects including opioid-like toxicity, hepatotoxicity, seizures, withdrawal syndrome, and cardiovascular complications, with the FDA explicitly warning against its use. 1
Acute/Short-Term Side Effects
Neurological Effects
- Opioid-like toxicity: Respiratory depression, sedation, altered mental state, loss of consciousness, and lethargy 2, 3
- Seizures: Particularly with chronic use 1, 4
- CNS stimulation or depression depending on dose 5, 4
- Confusion, dizziness, and delirium 6
Cardiovascular Effects
Gastrointestinal Effects
Other Acute Effects
Serious/Life-Threatening Complications
Hepatotoxicity
Kratom causes cholestatic liver injury that can progress to liver transplantation in severe cases 7. The pattern is predominantly cholestatic, presenting with:
- Jaundice
- Elevated liver enzymes (transaminases and bilirubin)
- In 4 documented cases, progression to liver transplantation was required 7
- Most cases improve with kratom cessation, but monitoring is essential 7
Respiratory Depression
- Variable response to naloxone - some cases respond, others do not 3
- Risk of delayed or recurrent respiratory depression even after initial naloxone response 3
- Extended observation periods are necessary following reversal attempts 3
Withdrawal Syndrome
Kratom must be tapered, not abruptly stopped, particularly when using >5-15 g per day 1. Withdrawal symptoms include:
- Irritability and restlessness
- Anxiety
- Sleep disturbances
- Appetite changes
- Abdominal pain
- Muscle aches
- Symptoms typically occur within 3 days of cessation and last up to 14 days 8
Long-Term/Chronic Use Effects
Addiction Potential
- Opioid agonist properties lead to tolerance and physical dependence 1
- Risk of developing kratom use disorder with chronic use 5, 4
- Addictive potential similar to opioids 4
Neurological
Psychiatric
- Mood disorders
- Anxiety exacerbation
- Potential for psychosis at high doses 6
Critical Drug Interactions
Cytochrome P450 Interactions
Kratom inhibits CYP3A4 and CYP2D6 4, 6, creating potential interactions with:
- Warfarin (very high risk) 8
- Buprenorphine (high risk) 8
- Tacrolimus (high risk) 8
- Chemotherapeutic agents metabolized by these enzymes 8
Serotonergic Medications
Risk of serotonin syndrome when combined with:
- SSRIs/SNRIs
- Tramadol
- Meperidine
- Other serotonergic agents 6
CNS Depressants
Additive sedation and respiratory depression with:
Perioperative Considerations
Kratom should be discontinued before surgery 1:
- Ideally held for 2 weeks preoperatively
- Must be tapered (not abruptly stopped) due to withdrawal risk 1
- Opioid-like properties complicate anesthetic management 1
- May increase anesthetic requirements 1
- Risk of withdrawal during perioperative period if not properly managed
Special Populations at Risk
Polysubstance Users
- Most kratom-associated fatalities involve polysubstance use 2, 6
- Confounding substances complicate attribution of adverse effects 2
- Enhanced toxicity when combined with other substances 6, 3
Pregnant Women
Patients with Liver Disease
- Baseline liver disease increases risk of hepatotoxicity 7
- Only 9% of reported liver injury cases had pre-existing liver disease, indicating risk even in healthy individuals 7
Critical Clinical Pitfalls
- Kratom is not detected on standard toxicology screens - must specifically request mitragynine testing 6
- Product variability is extreme - alkaloid content varies widely between products, making dose-effect relationships unpredictable 5, 4
- Naloxone response is inconsistent - do not assume naloxone will reverse toxicity 3
- Extended monitoring required - even after apparent reversal, delayed respiratory depression can occur 3
- Abrupt cessation causes withdrawal - always taper 1
FDA Position
The FDA explicitly warns against kratom use and seeks to make 7-hydroxymitragynine (a key kratom alkaloid) a controlled substance 1, 9. The Society for Perioperative Assessment and Quality Improvement (SPAQI) does not recommend use of kratom due to potential for serious adverse effects 1.